Home › Type 2 Diabetes › California › Los Angeles
Type 2 Diabetes clinical trials in Los Angeles, CA
16 studies for Type 2 Diabetes are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
RecruitingPhase 3
- Downtown LA Res Ctr. Inc., Los Angeles
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Inglewood Clinical, Los Angeles
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Los Angeles
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
RecruitingPhase 2
- Los Angeles Institute for Metabolic Research, Los Angeles
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RecruitingPhase 2
- Los Angeles Institute for Metabolic Research, Los Angeles
- Velocity Clinical Research, Los Angeles, Los Angeles
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RecruitingPhase 3
- VAGLAHS Clinical Research Center (CRC), Los Angeles
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Los Angeles
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RecruitingPhase 3
- Division of Endocrinology, Diabetes, and Metabolism, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Recruiting
- University of Southern California, Los Angeles
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Recruiting
- University of Southern California, Los Angeles
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
RecruitingObservational study
- Children's Hospital Los Angeles, Los Angeles
Type 2 Continuous Glucose Monitoring Academy
Recruiting
- Children's Hospital Los Angeles, Los Angeles
New T-UP: Engaging Vulnerable Students in Diabetes Prevention
Recruiting
- University of California, Los Angeles, Los Angeles
Implementation of Team Clinic for Type 2 Diabetes (TCT2)
Recruiting
- Children's Hospital Los Angeles, Los Angeles
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Recruiting
- Angel City Research, Los Angeles
- Clemente Clinical Research, Los Angeles
DETERMINE: Detemir vs NPH
RecruitingPhase 2
- University of California, Los Angeles, Los Angeles
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL25 studies
- Boston, MA20 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Miami, FL19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- San Diego, CA17 studies
- Atlanta, GA17 studies
- Birmingham, AL16 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.